Statistics for Applied Therapeutics (id:6952 APLT)

Valuation metrics

Market cap

1.05B

Enterprise value

941.00M

Trailing P/E (ttm)

-6.71

Forward P/E

-19.59

PEG ratio

-19.59

Price/Sales (ttm)

-4,945.13

Price/Book (mrq)

176.67

Enterprise Value/Revenue

-4,438.70

Enterprise Value/EBITDA

-10.20

Overview

Shares outstanding

116.36M

Float

84.77M

Shares short

12.14M

% Held by insiders

0.05%

% Held by institutions

0.95%

Average volume (10 days)

2.33M

Average volume (90 days)

Price summary

52-Week low

1.79

52-Week high

10.62

52-Week change

80.89%

Beta

2.02

50-Day moving average

8.06

200-Day moving average

5.89

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-24,379.51%

Operational effectiveness

Return on assets

-76.01%

Return on equity

698.49%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-92,284,000.00

Net income to common (ttm)

-187,310,000.00

Diluted EPS (ttm)

-1.42

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

98.87M

Total cash per share (mrq)

0.85

Total debt (mrq)

1.97M

Total Debt/Equity (mrq)

33.45

Current ratio (mrq)

105.70%

Book value per share (mrq)

0.05

Cash flow

Cash flow statement

-81,841,000.00

Levered free cash flow (LFCF)

-3,580,125.00